NVO Novo Nordisk A/S
9,856
$124.59
$1.54
(1.25%)
| Watchers | 9,856 |
| 52-Wk Low | $75.56 |
| 52-Wk High | $138.28 |
| Market Cap | $415.93B |
| Volume | 3.64M |
| 52-Wk High | $138.28 |
| 52-Wk Low | $75.56 |
Five Simple Policies To Reset America's "Rigged" Health SystemZero Hedge • about 8 hours ago
Five Simple Policies To Reset America's "Rigged" Health System
Calley Means, a one-time consultant for big food and pharmaceutical companies in the Washington, DC, swap and now the...
Share to Feed
This is not the first time the tech mogul has seemingly backed the blockbuster drug. Last year, Musk claimed that Ozempic was affecting food sales at Walmart.
read more...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market...
If Soranus of Ephesus were alive today he'd be mighty surprised.Like his modern-day counterparts in the medical field, the 2nd Century Greek physician considered obesity to be a disease, and he...
At least 25,000 Americans are beginning treatment with Novo Nordisk's Wegovy each week and that figure is growing, the company said.The Danish pharmaceutical giant, which has been ramping up...
Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update
Amgen's shares soared in premarket trading in New York following the drug maker's...
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower...
Futures Gain Boosted By Apple's Blowout Buyback, Dollar Drops Ahead Of Payrolls
US stock futures pointed to further strength on Wall Street ahead of the April jobs report after solid...
:max_bytes(150000):strip_icc()/GettyImages-1926853212-4765545081834119af7b45c72dfe53f5.jpg)
News of the day for May 3, 2024
NurPhoto / Contributor / Getty Images
U.S. stock futures are higher as investors await monthly jobs data and digest a slew of earnings reports; Apple (AAPL...
Novo Nordisk responded this week to the Federal Trade Commission's (FTC) suggestion that it filed 'junk' patents to prevent competition and raise prices. Moderna stock surged on Thursday after its...